Back to Search Start Over

PGE2-EP3 signaling exacerbates hippocampus-dependent cognitive impairment after laparotomy by reducing expression levels of hippocampal synaptic plasticity-related proteins in aged mice.

Authors :
Xiao JY
Xiong BR
Zhang W
Zhou WC
Yang H
Gao F
Xiang HB
Manyande A
Tian XB
Tian YK
Source :
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2018 Oct; Vol. 24 (10), pp. 917-929. Date of Electronic Publication: 2018 Feb 27.
Publication Year :
2018

Abstract

Aim: Multifactors contribute to the development of postoperative cognitive dysfunction (POCD), of which the most important mechanism is neuroinflammation. Prostaglandin E2 (PGE2) is a key neuroinflammatory molecule and could modulate hippocampal synaptic transmission and plasticity. This study was designed to investigate whether PGE2 and its receptors signaling pathway were involved in the pathophysiology of POCD.<br />Methods: Sixteen-month old male C57BL/6J mice were exposed to laparotomy. Cognitive function was evaluated by fear conditioning test. The levels of PGE2 and its 4 distinct receptors (EP1-4) were assessed by biochemical analysis. Pharmacological or genetic methods were further applied to investigate the role of the specific PGE2 receptors.<br />Results: Here, we found that the transcription and translation level of the EP3 receptor in hippocampus increased remarkably, but not EP1, EP2, or EP4. Immunofluorescence results showed EP3 positive cells in the hippocampal CA1 region were mainly neurons. Furthermore, pharmacological blocking or genetic suppression of EP3 could alleviate surgery-induced hippocampus-dependent memory deficits and rescued the expression of plasticity-related proteins, including cAMP response element-binding protein (CREB), activity-regulated cytoskeletal-associated protein (Arc), and brain-derived neurotrophic factor (BDNF) in hippocampus.<br />Conclusion: This study showed that PGE2-EP3 signaling pathway was involved in the progression of POCD and identified EP3 receptor as a promising treatment target.<br /> (© 2018 John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1755-5949
Volume :
24
Issue :
10
Database :
MEDLINE
Journal :
CNS neuroscience & therapeutics
Publication Type :
Academic Journal
Accession number :
29488342
Full Text :
https://doi.org/10.1111/cns.12832